4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001228684-26-000002
Director sold 12,500 shares at an average $68.79 ($859,819)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LINK WILLIAM J PHD Director | 2026-03-16 | Sale 10b5-1 | −3,629 | $68.09 | $247,099 | 125,203 | D |
| LINK WILLIAM J PHD Director | 2026-03-16 | Sale 10b5-1 | −8,378 | $69.03 | $578,333 | 116,825 | D |
| LINK WILLIAM J PHD Director | 2026-03-16 | Sale 10b5-1 | −493 | $69.75 | $34,387 | 116,332 | D |
| Open-market sales · 12,500 sh · avg $68.79 · $859,819 | |||||||
Loading xslF345X06/wk-form4_1773864674.xml…